Lumos Pharma Inc (LUMO)
4.30
-0.03
(-0.69%)
USD |
NASDAQ |
Nov 22, 11:13
Lumos Pharma Profit Margin (Quarterly): -1.03K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.03K% |
| June 30, 2024 | -1.55K% |
| March 31, 2024 | -6.33K% |
| December 31, 2023 | -1.14K% |
| September 30, 2023 | -118.6K% |
| June 30, 2023 | -1.69K% |
| March 31, 2023 | -1.06K% |
| December 31, 2022 | -1.61K% |
| September 30, 2022 | -1.46K% |
| June 30, 2022 | -3.03K% |
| March 31, 2022 | -6.95K% |
| December 31, 2021 | -2.56K% |
| September 30, 2021 | |
| June 30, 2021 | -86.70K% |
| March 31, 2021 | |
| December 31, 2020 | -6.04K% |
| September 30, 2020 | |
| June 30, 2020 | -16.22K% |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -5.23K% |
| September 30, 2018 | -6.17K% |
| Date | Value |
|---|---|
| June 30, 2018 | -768.8% |
| March 31, 2018 | -184.9% |
| December 31, 2017 | -48.23% |
| September 30, 2017 | -20.03K% |
| June 30, 2017 | -161.3% |
| March 31, 2017 | -757.4% |
| December 31, 2016 | -41.23% |
| September 30, 2016 | -1.75K% |
| June 30, 2016 | -1.61K% |
| March 31, 2016 | -415.6% |
| December 31, 2015 | -63.55% |
| September 30, 2015 | -1.88K% |
| June 30, 2015 | -189.3% |
| March 31, 2015 | 28.55% |
| December 31, 2014 | 69.54% |
| September 30, 2014 | |
| June 30, 2014 | -4.32K% |
| March 31, 2014 | -2.77K% |
| December 31, 2013 | -736.1% |
| September 30, 2013 | |
| June 30, 2013 | -3.05K% |
| March 31, 2013 | -2.63K% |
| December 31, 2012 | -374.6% |
| September 30, 2012 | |
| June 30, 2012 | -1.07K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-118.6K%
Minimum
Sep 2023
-1.03K%
Maximum
Sep 2024
-17.06K%
Average
-2.56K%
Median
Dec 2021
Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp | 11.12% |
| Calidi Biotherapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -183.0% |
| Return on Assets | -112.4% |
| Return on Invested Capital | -183.0% |
| Operating Margin (Quarterly) | -1.05K% |
| Return on Net Operating Assets | -5.83K% |